Evidence map›Paper›PMID 18840411›Full record

ArticleBiochemical pharmacology2008

c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.

Travis W Day, Su Huang, Ahmad R Safa

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Induction of apoptosis on ovarian adenocarcinoma cells, A2780 by tricyclohexylphosphanegold (I) mercaptobenzoate derivatives via intrinsic and extrinsic pathways.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  9. Article
  10. Article
  11. FLIP(L): the pseudo-caspase.The FEBS journal · 2020
    Review
  12. Purified Tea (International journal of molecular sciences · 2020
    Article
  13. Article
  14. Cell-mediated immune resistance in cancer.Cancer drug resistance (Alhambra, Calif.) · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Travis W DayDepartment of Pharmacology and Toxicology, Indiana University Simon Cancer Center, Indiana University School of Medicine, 1044 West Walnut Street R4-119, Indianapolis, IN 46202, USA.
Su Huang
Ahmad R Safa
Indiana University Health · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Role of Proteinase-3 in Apoptosis and Drug ResistanceR01CA101743 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAFA, AHMAD R · 2003 to 2007
$1.5M
NCI NIH HHS R01 CA 101743NCI NIH HHS R01 CA101743
6 · The paper itself

Abstract

Cellular-FLICE inhibitory protein (c-FLIP) is an inhibitor of apoptosis downstream of the death receptors Fas, DR4, and DR5, and is expressed as long (c-FLIP(L)) and short (c-FLIP(S)) splice forms. We found that the knockdown of c-FLIP using small interfering RNA (siRNA) triggered ligand-independent caspase-8- and -9-dependent spontaneous apoptosis and decreased the proliferation of MCF-7 breast cancer cells. Further analysis revealed that an apoptotic inhibitory complex (AIC) comprised of DR5, FADD, caspase-8, and c-FLIP(L) exists in MCF-7 cells, and the absence of c-FLIP(L) from this complex induces DR5- and FADD-mediated caspase-8 activation in the death inducing signaling complex (DISC). c-FLIP(S) was not detected in the AIC, and using splice form-specific siRNAs we showed that c-FLIP(L) but not c-FLIP(S) is required to prevent spontaneous death signaling in MCF-7 cells. These results clearly show that c-FLIP(L) prevents ligand-independent death signaling and provides direct support for studying c-FLIP as a relevant therapeutic target for breast cancers.

Indexed as

ApoptosisBreast NeoplasmsCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 8Caspase 9Cell Line, TumorFas-Associated Death Domain ProteinGene SilencingHumansLigandsProtein IsoformsReceptors, TNF-Related Apoptosis-Inducing LigandRNA, Small InterferingCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 8Caspase 9Fas-Associated Death Domain ProteinLigandsProtein IsoformsReceptors, TNF-Related Apoptosis-Inducing LigandRNA, Small Interfering

Identifiers

PMID18840411
PMCPMC2610355
OpenAlexW2018725927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.